What your health practitioner is examining on Medscape.com:

APRIL 23, 2020 — Through a recent webinar by the American Culture of Nephrology, Anitha Vijayan, MD, professor of medicine in the Division of Nephrology at Washington University University of Medication in St. Louis gave a presentation on the Useful Factors of RRT in Hospitalized People with AKI or ESKD. We questioned her to share some of her insights with Medscape.

This interview was edited for duration and clarity.

What are the indications for renal alternative remedy (RRT) in patients with COVID-19?

Anitha Vijayan, MD:  The indications for RRT in patients with acute kidney injury (AKI) of any etiology are hyperkalemia metabolic acidosis quantity overload, uremic manifestations these kinds of as uremic encephalopathy, or pericarditis. We also consider the severity of oliguria.

Are there any indications particular to COVID-19 or are they typical of ICU patients with AKI?

COVID-19 patients have a very high likelihood of respiratory failure and sometimes it really is tricky to distinguish irrespective of whether this is from quantity overload or from pneumonia. Respiratory failure may perhaps be the driving power for initiation of renal alternative remedy in these patients, and maybe in that regard they have a tendency to be a tiny diverse.

Do you recommend that professional medical administration methods be fatigued ahead of utilizing RRT?

If the only rationale to initiate RRT is respiratory failure and fluid overload, we recommend a trial of loop diuretics initially. Of training course, diuretics must not be made use of if you suspect the affected individual is previously hypovolemic, or if they have other indications for RRT these kinds of as uremic manifestation or critical hyperkalemia, and many others.

Are you delaying RRT for a longer time since of the scarcity of equipment or any clinical reasons?

I would say mainly for handling methods. For the reason that if we commence alternative remedy very early for all these patients, we will run out of equipment and other materials.

Is constant renal alternative remedy (CRRT) the most popular modality?

CRRT is the most popular modality for any critically unwell affected individual with AKI, particularly those people who have hemodynamic instability. That’s the scenario, irrespective of whether or not they have COVID-19.

Is there any preference for constant convective clearance hemodialysis (CVVH) in excess of constant veno-venous hemodialysis (CVVHD)?


No. Convective clearance has not been shown to be excellent to diffusive clearance, as considerably as affected individual results are anxious. As I stated in the webinar, you must use no matter what modality is out there at your institution.

What about source-intelligent in phrases of preserving dialysate?

In most scenarios the very same prepackaged remedies are made use of both as alternative fluid (CVVH) or dialysate (CVVHD). Sure equipment like the Tablo can generate their have dialysate, and can only be made use of for CVVHD, and not CVVH. But source-intelligent, there is not any rationale to prefer one particular modality in excess of the other. It all depends on no matter what equipment are out there at your institution.

One particular of your tips is to minimize movement prices to increase methods. Can you elaborate?

Generally for CRRT, we use an effluent movement price of about twenty-25 mL/kg/hr. That advice is primarily based on the ATN and RENAL studies, published in 2008 in 2009, respectively, which in contrast reduce movement prices to greater movement prices, and did not exhibit any change as considerably as results are anxious. However, no person has in contrast twenty-25 mL/kg/hr to an even reduce movement price these kinds of as fifteen mL/kg/hr so, twenty-25 mL must serve as the conventional.

What I was recommending is that as soon as patients achieve metabolic command (secure electrolytes, acidosis less than command), then you can consider lowering the movement prices to about fifteen mL/kg/hr to preserve methods.

Does prolonged intermittent RRT make it possible for you to treat much more patients with one particular equipment?

We use greater movement prices for a shorter duration with PIRRT. We do CRRT 24 hrs a working day, but with PIRRT you can probably use the equipment for two (10 hour treatment plans) to 3 patients (6 hour treatment plans) when permitting time to thoroughly clean and disinfect the equipment in concerning. To be certain they’re acquiring a fair amount of clearance, we boost the movement price significantly to approximate a whole of twenty-25 mL/kg/hr for 24 hrs. Fundamentally, you estimate the fluid necessity for 24 hrs per working day and divide that by the quantity of hrs you’re really heading to do.


You can do PIRRT on the very same equipment as CRRT and it allows one particular equipment to be made use of for two or 3 patients but it continue to demands the very same quantity of fluids.

What about anticoagulation for the duration of RRT?

Anticoagulation is very essential in COVID-19, not only in my encounter but also from speaking about with some others across the place. Each one individual instructed me that anticoagulation is critical in patients on RRT, if not the equipment are clotting often and we are squandering filters and of training course blood.

Systemic anticoagulation with heparin worked for us, but some others have stated that their patients ended up clotting inspite of heparin, and they have made use of regional citrate anticoagulation or direct thrombin inhibitors these kinds of as argatroban.

If your centre is not utilizing citrate previously, I don’t recommend beginning it now since citrate is a intricate protocol, even in the finest fingers. In my belief, utilizing it unexpectedly can be a setup for errors and affected individual protection issues.

What about vascular access?

It’s essential that the proper duration of the catheter be picked out for the proper vein, and our most popular order for vascular access is the proper inner jugular (IJ) vein, the femoral veins, and then the remaining IJ.

One particular of your tips was a cheat sheet for folks who may not be made use of to positioning these catheters, proper?

Indeed, we created a cheat sheet that we discussed with our critical treatment colleagues for the duration of our daily rounds and created certain it was out there for them in the ICU.

Access Website

Preferred Catheter Length (cm)

Ideal inner jugular




Still left inner jugular


Do you recommend multidisciplinary rounds?

Indeed, the multidisciplinary rounds have been very handy for collaborating with the critical treatment medical professionals having treatment of these patients. We do them each individual morning, primarily with the critical treatment medical professionals from pulmonary or anesthesia.

What would you suggest hospitals preparing for a surge — must they be obtaining/borrowing equipment or stockpiling dialysate?

No one would recommend stockpiling dialysate since that indicates there’s considerably less availability for folks who definitely need it. I feel the finest solution is to discuss to your hospital leadership to get projections of affected individual volumes for your institution, and try out to put together for that.


We ended up blindsided by the amount of acute kidney personal injury and the need for RRT since we did not get a good deal of early experiences about this from other nations. To begin with all the discuss was about ventilators. The incidence in the US of critically unwell patients with AKI needing RRT seems to be about 25%. You could put together for that quantity at your institution.

Must centers be cross-teaching other specialties on how to established up and check RRT products?

I feel cross-teaching is essential. We are cross-teaching nurses in checking dialysis patients so that the dialysis nurses can get treatment of much more patients. At our institution, we prepared for that forward of time, and tackled it in our preparing paperwork.

You also confirmed some MacGyvering tricks for the equipment.

I tweeted two pics. One particular was with a affected individual who took place to be on ECMO [extracorporeal membrane oxygenation], and the tubing of the ECMO is extended enough to maintain the Prisma-Flex equipment outdoors the door.

The Prisma-Flex has an effluent bag that wants to be altered each individual two hrs. One particular of our nurses took that bag and hung it up on an IV pole and allow it drain by gravity back again into the rest room within the home alternatively of him getting to stand by the sink and

I would warning that affected individual protection constantly has to appear initially. When blood tubing extensions are additional, patients are at possibility for hypothermia and blood reduction. Affected individual protection constantly trumps any of these maneuvers.

Is there any issue about renal toxicity of the treatment plans for COVID-19?

I’m not informed of direct toxicity from these medicines at this time, but, like most medicines, any time patients have acute kidney personal injury, the doses have to be adjusted to reduce other kinds of toxicity from medication accumulation. 

Some of these patients will continue to need dialysis soon after discharge. Any concerns about that?

That’s a very essential issue which we are viewing in New York. Even ahead of COVID-19, I constantly instructed my critically unwell patients and their families that the kidneys are the previous organ to appear back again.


The need for dialysis constantly lasts for a longer time than the need for a ventilator. These patients have to have dialysis soon after they leave the ICU, and sometimes soon after they leave the hospital. Transitioning them to outpatient hemodialysis facilities has been tricky in some conditions, until they’re verified to be COVID negative. Services will accept them for remedy furnished they have repeat testing to prove that they’re negative for COVID.

Does that necessity indicate you have to maintain them in hospital for a longer time than you would ordinarily? 

Indeed. We may perhaps have to maintain them for a longer time to make certain that we have a facility who will accept them.

An additional nephrologist 


that kidney personal injury may perhaps be one particular of the top rated extended term sequelae from COVID-19. Would you agree?

Perhaps. People who suffer from AKI have extended-term repercussions, particularly if they have critical AKI. So they may perhaps be remaining with chronic kidney sickness. They will certainly need extended-term nephrology treatment and near stick to-up.

What about somebody who previously has some renal dysfunction pre-COVID-19?

Any time you have underlying CKD and you have AKI on top rated of that, your prognosis is worse than if you experienced just AKI.

The other inhabitants that we did not focus on considerably is the stop-stage kidney sickness inhabitants — these patients are previously susceptible to bacterial infections, as they have a tendency to be more mature, and to have a weaker immune technique. They are also much more uncovered since they’re sitting in a facility with other patients 3 instances a 7 days for dialysis.

We’ve experienced patients with stop-stage kidney sickness contract COVID-19. As considerably as their results, I don’t feel we have enough data to say how they fare in contrast to patients with COVID and acute kidney personal injury.

Is there everything else you would like to explain to our readers?

I would say that handling kidney sickness in COVID patients has been very complicated for every person across the US partly since we ended up not ready. It is somewhat surprising to me that we did not hear much more about the nephrology factors from other nations who ended up hit ahead of the United States. And we continue to need to study much more about the correct pathophysiology of the AKI from COVID-19 and its extended-term sequelae. 


Anitha Vijayan MD is on the Scientific Advisory Board for NxStage Fresenius Clinical Treatment.

Tricia Ward is an government editor at Medscape who mainly handles cardiology and nephrology. She is primarily based in New York Metropolis and you can stick to her 

on Twitter @_triciaward

Medscape Clinical News

© 2020 WebMD, LLC. All legal rights reserved.